Skip to main content

Oregon State Flag An official website of the State of Oregon »

Rulemaking advisory committees (RAC)

Advisory committees

Advisory committee meetings are open to the public. Due to time limitations and to ensure that public comments are correctly recorded, individuals are strongly encouraged to submit public comments in writing via email to [email protected].

Current committees

  • Drug Price Transparency RAC

    Proposed rulemaking process that aims to update and amend the current administrative rules related to the Oregon Prescription Drug Price Transparency (DPT) program

    Next meeting: Aug 22, 2024
    More details
  • Well-Woman Services RAC

    Proposed rulemaking process that aims to update and amend the current administrative rules related to Well-Woman visits

    More details
  • Manufacturer Fees SB 192 (2023) RAC

    The Prescription Drug Affordability Board (PDAB) has developed draft rules for manufacturer fees that are necessary for the operation of PDAB consistent with its authority under SB 192 (2023)..

    More details
  • Gender-Affirming Treatment (HB 2002) RAC

    HB 2002 prohibits a carrier offering a health benefit plan from denying or limiting coverage for medically necessary gender affirming treatment that is prescribed in accordance with accepted standards of care.

    More details